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Abstract
Changes in microRNA expression have been linked to a wide array of pathological states. However, little is known about the
regulation of microRNA expression. The let-7 microRNA is a tumor suppressor that inhibits cellular proliferation and
promotes differentiation, and is frequently lost in tumors. We investigated the transcriptional regulation of two let-7 family
members, let-7a-3 and let-7b, which form a microRNA cluster and are located 864 bp apart on chromosome 22q13.31.
Previous reports present conflicting data on the role of the NF-kB transcription factor in regulating let-7. We cloned three
fragments upstream of the let-7a-3/let-7b miRNA genomic region into a plasmid containing a luciferase reporter gene.
Ectopic expression of subunits of NF-kB (p50 or p65/RelA) significantly increased luciferase activity in HeLa, 293, 293T and
3T3 cells, indicating that the let-7a-3/let-7b promoter is highly responsive to NF-kB. Mutation of a putative NF-kB binding
site at bp 2833 reduced basal promoter activity and decreased promoter activity in the presence of p50 or p65
overexpression. Mutation of a second putative binding site, at bp 2947 also decreased promoter activity basally and in
response to p65 induction, indicating that both sites contribute to NF-kB responsiveness. While the levels of the
endogenous primary let-7a and let-7b transcript were induced in response to NF-kB overexpression in 293T cells, the levels
of fully processed, mature let-7a and let-7b miRNAs did not increase. Instead, levels of Lin-28B, a protein that blocks let-7
maturation, were induced by NF-kB. Increased Lin-28B levels could contribute to the lack of an increase in mature let-7a and
let-7b. Our results suggest that the final biological outcome of NF-kB activation on let-7 expression may vary depending
upon the cellular context. We discuss our results in the context of NF-kB activity in repressing self-renewal and promoting
differentiation.
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Introduction
miRNAs are non-coding, single-stranded, conserved RNAs of
,22 nucleotides that function as gene regulators in both animals
and plants [1]. miRNAs have been discovered to play a central
role in a wide variety of biological processes. They are initially
transcribed as primary transcripts (pri-miRNAs) and then cleaved
by the RNase III enzyme Drosha into 70- to 100-nt hairpin-
shaped precursors [2,3]. These pre-miRNAs are exported into the
cytoplasm and processed by the RNase III enzyme Dicer to their
mature form. Fully-processed miRNAs negatively regulate their
targets by binding to partially complementary sequences in the 39
UTR of target transcripts [4,5], leading to transcript instability or
inhibition of translation [6,7].
The let-7 microRNA was discovered in a chromosomal location
that affects terminal differentiation of seam cells in C. elegans [5]. In
humans and mice, there is an association between let-7, cell cycle,
and differentiation. Inhibition of let-7 in A549 lung cancer cells
increases cell proliferation rates, whereas let-7 overexpression
blocks cell-cycle progression [8,9]. Overexpression of let-7 in
primary human fibroblasts results in reduced cell proliferation and
an accumulation of cells in the G2/M phase of the cell cycle [10].
In C. elegans, mice and humans, let-7 expression is barely detectable
in embryonic stages but increases after differentiation and in
mature tissue [11,12,13]. The let-7 family of miRNAs is
consistently down-regulated in lung and colon cancers [8,14,15].
In lung cancers, low levels of let-7 correlate with shorter survival
after resection [8,14,16]. Low levels of let-7 are found in some stem
cell populations, and high expression of a let-7 target gene has been
used to enrich for stem cells from a mouse mammary epithelial cell
line [17].
Let-7 family members can be regulated transcriptionally or post-
transcriptionally. As one example of transcriptional activation,
MYC activation results in widespread repression of miRNA
expression, including let-7 family members [18]. Post-transcrip-
tional regulation can be mediated by Lin28B, which blocks the
maturation of primary-let-7 (pri-let-7) in embryonic stem cells
[19,20] by causing 39 uridylation of pre-let-7, thus rendering the
transcript resistant to Dicer processing [21]. In addition, the
KSRP RNA binding protein and hnRNP A1 have also been
reported to promote and inhibit the processing of pri-let-7,
respectively [22,23].
The NF-kB family of transcription factors is induced by
numerous stimuli including growth factors, DNA damaging
agents, cytokines, oxidants, and viral and bacterial pathogens
[24,25]. In response to activation, NF-kB family members
translocate to the nucleus, and regulate transcription of over 400
effector genes involved in immunoregulation, growth regulation,
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response involves homo or heterodimerization of five members of
the NF-kB family: p50 and its precursor p105 (NF-kB1), p52 and
its precursor p100 (NF-kB2), p65 (RelA), c-Rel and RelB. The
p65, RelB and c-Rel components contain transcriptional activa-
tion domains necessary for positive regulation of gene expression,
while the p50 and p52 subunits can repress transcription by
themselves or activate transcription in a complex with proteins
that contain transcriptional activation domains [26]. NF-kB
dimers bind promoters and enhancer regions containing the
consensus sequence 59 GGGRNWYCC 39, where N is any base,
R is a purine, W is an adenine or thymine and Y is a pyrimidine
[28].
Iliopoulos and colleagues reported that transient induction of
the Src oncogene in non-transformed human mammary epithelial
cells (MCF10A) results in production of the cytokine interleukin-6
(IL-6), which drives and maintains cells in a transformed state [29].
This epigenetic switch is mediated by the transcription factor NF-
kB, which then directly activates Lin28 transcription leading to
rapid reduction in mature let-7 levels. Since let-7 directly inhibits
IL-6 expression, levels of IL-6 increase. This further activates NF-
kB, leading to a positive feedback loop.
Whereas Iliopoulos and colleagues found that NF-kB directly
activates Lin28 and thereby reduces let-7 levels, Garzon and
colleagues report that NF-kB activates let-7 during granulocytic
differentiation of NB4 cells induced by all-trans-retinoic acid
(ATRA) [30]. This suggests that the final biological outcome of
NF-kB activation on let-7 expression may vary depending upon
the cellular context. We discovered that let-7 is regulated during
the transition from proliferation to quiescence [10] and wanted to
explore a potential role for NF-kB in this process. In this report,
we show that the let-7a-3 promoter is positively regulated by NF-
kB subunits in three different cell lines. Introduction of NF-kB
subunits also resulted in increased expression of pri-let-7a and pri-
let-7b, but did not result in a corresponding induction of the
processed let-7a or let-7b. This could reflect, in part, an NF-kB-
induced increase in the levels of Lin28B.
Methods
Computational analysis of the let-7a-3 promoter
The DNA sequence of the let-7a-3 promoter was analyzed with
PROMO. The PROMO software identifies putative transcription
factor binding sites with weight matrices representing consensus
recognition sequences for different transcription factors as defined
in the TRANSFAC database [31,32]. NF-kB binding sites
upstream of the let-7a-3 start site were identified.
Plasmids and promoter reporter constructs
Promoter regions were amplified from human genomic DNA
using the following primer sets: 1 Kb 59 ggtaccggacctcactctgct-
gcccccttggctgtgtgacatccagg and 1 Kb 39 aagcttggtgccgatgggactcc-
gtggcttc; 1.5 Kb 59 gccggtacctagacctttcaagtccacttgggcatggggagctga-
gag and 1.5 Kb 39 tggagatctgggcagtcggtcttggtgccgatgggactccgtgg-
cttc; 3 Kb 59 ggcggtaccctggcctctcctgtcacctagccaccgggc and 3 Kb 39
tggagatctaaagggcagtcggtcttggt. The PCR products were cloned into
the promoterless vector pGL3 Basic (Promega, Madison, Wiscon-
sin) using KpnI/HindIII and KpnI/BglII restriction sites to
generate pGL3-1Kb, pGL3-1.5Kb and pGL3-3Kb. Site-directed
mutagenesis was performed with the QuikChange Kit (Stratagene,
La Jolla, California) using the pGL3-1Kb vector as a template.
Mutations were introduced in the NF-kB recognition site at 2833
togenerate two distinct mutant plasmids.Inthefirstmutant plasmid
(pGL3-1Kb-m1), the original sequence GGGGAGCCCC was
changed to GGGCAGAACC by introducing three nucleotide
substitutions using primers: 59 ttcccctgctagggcagaaccgaggccctctca
and 39 tgagagggcctcggttctgccctagcaggggaa. In the second mutant
plasmid (pGL3-pGL3-1Kb-m2), the sequence was changed to
GAGCCCC, thus introducing a 3-bp deletion using primers: 59
ccacgttcccctgctagagccccga and 39 tcggggctctagcaggggaacgtgg. The
NF-kB recognition site at 2947 was also mutated (pGL3-1Kb-m3)
using site-directed mutagenesis. The sequence was changed from 59
AGCTTTTCCCC to 59 ATTTCCCC using primers: 59
gtatctgccccctcatttccccaggaaggt and 39 accttcctggggaaatgagggggca-
gatac. pCMV2 vectors containing no insert, or the p50 or p65
subunits of NF-kB cloned downstream of the CMV promoter, were
a generous gift of the Guttridge Lab, Ohio State University [30].
Immunoblot analysis
HeLa or HEK293T cells were transfected with an empty vector
control, a plasmid encoding p50, or a plasmid encoding p65 using
Lipofectamine 2000 (Invitrogen, Carlsbad, California) according
to the manufacturer’s instruction. Cells were lysed in RIPA buffer
containing protease and phosphatase inhibitors [10 mM NaPO4
pH 7.2, 0.3 M NaCl, 0.1% SDS, 1% NP40, 1% Na deoxycholate,
2 mM EDTA, protease inhibitor cocktail (Roche, Basel, Switzer-
land)]. Protein concentration was determined by the Lowry
method using the Bio-Rad DC Protein Assay Kit II (Bio-Rad,
Hercules, California) as described by the manufacturer. Equal
amounts of total cellular proteins were resolved on SDS-PAGE
and electro-transferred onto a PVDF membrane, which was then
incubated with an antibody to p50 (Cell Signaling, Beverly, MA,
1:1000 dilution), p65 (Cell Signaling, 1:1000), Lin28B (Cell
Signaling 1:1000) or Flag (Sigma-Aldrich, St. Louis, MO,
1:2000). Secondary antibodies conjugated with horseradish
peroxidase (GE Healthcare, Little Chalfont, United King-
dom,1:3000 dilution) and enhanced chemiluminescence (Pierce,
Thermo Fisher Scientific, Waltham, Massachusetts) were used to
detect the antigen. Membranes were stripped using Restore
Western Blot Stripping Buffer (Thermo Fisher Scientific) and
immunoblotted with GAPDH (Abcam, Cambridge, Massachu-
setts, 1:5000 dilution) as a loading control.
Luciferase reporter assays
Promoter activity was determined by co-transfection of the
pGL3 promoter reporter with a plasmid designed to serve as a
control for transfection efficiency, pRL-CMV (Renilla luciferase
plasmid, Promega, Madison, Wisconsin), into four cell types.
HEK293 (generously provided by the Flint laboratory, Princeton
University), HEK293T (ATCC, Manassas, Virginia), NIH3T3
(ATCC) and HeLa (ATCC) cells were grown in DMEM
(Invitrogen-GIBCO, Carlsbad, California) supplemented with
10% fetal bovine serum (FBS, Atlanta Biologicals, Lawrenceville,
Georgia). Cells were grown to a cell density of 60–70% in 12-well
dishes and then transiently transfected with 2 mg of experimental
firefly luciferase plasmids, 0.2 mg of pRL-CMV, and 2 mg of empty
vector plasmids or plasmids encoding the p50 or p65 NF-kB
subunits using Lipofectamine 2000 (Invitrogen). Twenty-four
hours post-transfection, cells were harvested and luciferase activity
was measured using a GloMax
TM 96-well Microplate Luminom-
eter (Promega). The ratio of firefly to Renilla luciferase activity was
determined.
Transfection of NF-kB subunits
Lipofectamine 2000 (Invitrogen) was used to transfect 24 mgo f
plasmids encoding the NF-kB subunits p50, p65 or the pRL-CMV
control vector into HEK293T cells according to the manufactur-
er’s protocol. Media was replaced 4 hours after transfection and
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start of the transfection.
Real time PCR
To monitor levels of processed let-7a and let-7b, real-time PCR
was performed with stem-loop primers and probes designed
specifically to detect let-7a or let-7b (Applied Biosystems, Carlsbad,
California). Total RNA was isolated using TRIzol Plus RNA
purification system (Ambion, Life Technologies, Grand Island,
New York). miRNA abundance was measured by real time PCR
on an Applied Biosystems 7900HT Sequence Detection System
using TaqMan microRNA assays according to the manufacturer’s
protocol (Applied Biosystems). The standard curve method was
used to quantify unknown miRNA abundance and the threshold
cycle (CT) was defined as the fractional cycle number at which the
fluorescence passed a fixed threshold. The ratio of the amount of
miRNA to the amount of a U6 small nuclear RNA control was
determined for each sample.
To detect pri-let-7 primary transcript, primers and probes
provided with the TaqMan Pri-miRNA Assays (Applied Biosys-
tems) were used. Two mg of RNA were reverse transcribed with
the High Capacity RNA-to-cDNA Kit (Applied Biosystems).
Standard curve dilutions of the cDNAs were prepared (1:10 to
1:10000) and real-time PCR was performed as described above.
The ratio between fluorescence from pri-let-7 detection and that of
the control housekeeping gene b-actin, which was measured using
Taqman b-actin Gene Expression Assays, was determined.
To detect Lin28B mRNA, RNA was reverse-transcribed with
the High Capacity RNA-to-cDNA Kit (Applied Biosystems).
Probes and primers were designed using the Integrated DNA
Technologies PrimeTime qPCR Assay Design Tool. Real-time
PCR was performed with the following mix: 25 mL Universal 26
Master Mix, 5 mL cDNA template, 3.3 mL primers (2 mM), 2.5 mL
probe (2 mM) and 10.9 mLd H 2O. Lin28B fluorescence was
normalized to the b-actin control as mentioned above.
Results
The let-7a-3 promoter is induced by NF-kB subunits
In order to determine the minimum required region for the let-
7a-3/let-7b microRNA cluster, the sequences 1 kb, 1.5 kb and
3 kb upstream of the let-7a-3 miRNA were cloned into the pGL3
vector upstream of the gene encoding firefly luciferase to generate
vectors pGL3-1Kb, pGL3-1.5Kb and pGL3-3Kb, and promoter
activity was monitored. HEK293T cells were transfected with let-7
promoter luciferase reporters or control plasmids along with a
normalization plasmid for transfection efficiency expressing
Renilla luciferase. Protein lysates collected 48 hours post-transfec-
tion were analyzed for the ratio of firefly to Renilla luciferase
activity. Fold-change was determined with respect to pGL3
activity. The let-7 promoter plasmids pGL3-1Kb and pGL3-
1.5Kb produced significantly higher luciferase activity than the
control plasmid (p,0.0001). Thus, even just 1 kb of the let-7a-3
promoter was sufficient to induce promoter activity without the
introduction of other factors (Figure 1). Promoter activity was
lower for the pGL3-3Kb plasmid suggesting that there may be
repressive elements between 1.5 kb and 3 kb upstream from the
let-7a-3 promoter.
In order to investigate NF-kB responsiveness of the let-7a-3
promoter, plasmids expressing p50 and p65 subunits of NF-kB
were transfected into HeLa cells. Immunoblotting confirmed that
the appropriate proteins were overexpressed (Figure 2A). NIH3T3
cells, HeLa cells, and HEK293T cells were transfected with a let-7
promoter reporter plasmid, plasmids expressing constituents of the
NF-kB transcription factor (p50 or p65) or an empty vector, and a
normalization plasmid expressing Renilla luciferase (Figure 2B).
Samples co-transfected with the p50 or p65 subunits exhibited
significantly higher activity than samples co-transfected with the
empty control plasmid. Luciferase activity was observed for the
three different vectors containing the let-7 promoter, indicating
that the important elements were likely to be within the first 1 kb
upstream of transcriptional start. In all three cell lines, a strong
induction was observed with p65 transfection (p,0.0001). The
extent to which p50 overexpression induced luciferase activity
varied among the cell lines, with the highest induction in
HEK293T cells and more modest induction in HeLa and 3T3
cells.
Contribution of specific NF-kB binding sites to the NF-kB
responsiveness of the let-7a-3 promoter
We analyzed the DNA sequence of the let-7a-3 promoter region
with PROMO software and discovered multiple NF-kB binding
sites. These included a binding site that had been previously
reported at 2833 as well as binding sites 2947 bp upstream,
2649 bp upstream, 2292 bp upstream and 243 bp upstream of
the let-7a-3 microRNA (Figure 3A). Garzon and colleagues
reported that the NF-kB binding site at bp 2833 is critical for
transcription factor activity [30]. To test the role of this particular
NF-kB binding site in NF-kB-mediated let-7 promoter regulation,
site-directed mutagenesis was performed on the putative NF-kB
recognition site at 2833 bp in the 1 kb plasmid to create two
distinct mutant plasmids, pGL3-1Kb-m1 and pGL3-1Kb-m2. In
the pGL3-1Kb-m1 plasmid, the original sequence, GGGGAG-
CCCC, was changed to GGGCAGAACC by introducing three
nucleotide substitutions. In the pGL3-1Kb-m2 plasmid, the
sequence was changed to GAGCCCC, thus introducing a 3-bp
deletion.
Transfection of wild-type or mutant reporters, NF-kB subunits
or an empty vector control, and a transfection efficiency
normalization control Renilla plasmid was performed in
HEK293 cells and HEK293T cells. Mutagenesis of the NF-kB
recognition site at 2833 bp reduced basal expression levels of the
plasmids, that is, activity without p50 or p65 ectopic expression
(Figure 3B). In HEK293 cells, luciferase levels in cells transfected
Figure 1. The upstream genomic region of let-7a-3/b microRNAs
confers transcriptional activity. HEK293T cells were transfected
with pGL3, pGL3-1Kb, pGL3-1.5Kb or pGL3-3Kb. Cells were collected
48 hours post transfection and luciferase activity was determined. Data
are from two biological replicates, each with two technical replicates.
Mean values are indicated and error bars designate the standard
deviation.
doi:10.1371/journal.pone.0031240.g001
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than luciferase levels in cells transfected with pGL3-1Kb
(p,0.0001). In HEK293T cells, luciferase levels for pGL3-1Kb-
m1 were significantly lower than those in cells transfected with
pGL3-1Kb. In HEK293T cells transfected with pGL3-1Kb-m2,
luciferase activity was reduced but did not reach statistical
Figure 2. The let-7a-3 promoter is regulated by overexpression of NF-kB transcription factor subunits p50 or p65. A. Transfection of
plasmids expressing p50 or p65 results in increased levels of the encoded protein. HeLa cells were transfected with an empty vector or vectors
expressing NF-kB subunits p50 or p65. Protein lysates were collected 48 hours post-transfection and levels of the encoded protein were determined
with immunoblotting. GAPDH levels were monitored as a loading control. B. Transfection of plasmids expressing p50 or p65 results in increased
promoter activity. Cells were co-transfected with a Renilla luciferase reporter; a control plasmid (vector) or plasmids that overexpress the p50 or p65
subunits of the NF-kB transcription factor; and the pGL3 vector or the pGL3 vector with 1 Kb, 1.5 Kb or 3 Kb of the let-7a3 promoter region
subcloned upstream of luciferase (repesented as pGL3-1Kb, pGL3-1.5Kb or pGL3-3Kb, respectively). Luciferase assays were performed to determine
the amount of firefly and Renilla luciferase in each sample. For HEK293T cells, two technical replicates were performed for each of two biological
replicates. For NIH 3T3 and HeLa, four technical replicates were performed for each of the two biological replicates. The ratio of firefly to Renilla
luciferase was determined, and the fold change compared with the pGL3 vector was calculated. Mean values are plotted and error bars reflect
standard deviations.
doi:10.1371/journal.pone.0031240.g002
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kB binding site at 2833 bp significantly reduced basal let-7
promoter activity so that luciferase levels returned to a level close
to, but in most cases distinguishable from, the levels in empty
vector transfected cells. This suggests that the 1 Kb let-7 promoter
fragment also contains other sites that contribute to expression.
Mutagenesis of the 2833 bp site also reduced but did not
eliminate the responsiveness of the let-7 promoter to overexpres-
sion of p50 or p65 in both HEK293 and HEK293T cells
(Figure 3B). In HEK293 cells, for both pGL3-1Kb-m1 and pGL3-
1Kb-m2, luciferase levels in cells transfected with p50 were lower
than in cells transfected with pGL3-1Kb and p50 (p,0.0001). For
Figure 3. NF-kB regulates the let-7a-3 promoter activity in part through a binding site at 2833 bp. A. The genomic organization of the
let-7a-3/let-7b miRNA cluster (chromosome 22) is shown. The location of the putative NF-kB binding site at 2833 bp is indicated. Portions of the
genomic region upstream of let-7a-3 that were subcloned to create the 1 kb, 1.5 kb and 3 kb plasmids are also depicted. B. HEK293 or HEK293T cells
were co-transfected with a Renilla luciferase reporter; a negative control expression plasmid (vector); and pGL3, pGL3-1Kb containing 1 Kb of wild-
type let-7a-3 promoter, or one of two clones of the same vector in which the putative NF-kB binding site at 2833 bp was mutated (pGL3-1Kb-m1 and
pGL3-1Kb-m2). Luciferase activity was monitored and the ratio of firefly to Renilla luciferase was determined. The fold-change compared with the
pGL3 vector is plotted. Two biological replicates were performed and for each biological replicate, three technical replicates were analyzed. Mean
values are indicated and error bars designate the standard deviation. Asterisks indicate p,0.001.
doi:10.1371/journal.pone.0031240.g003
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or pGL3-1Kb-m2 was transfected, but the decrease did not
achieve statistical significance. In HEK293T cells, levels for pGL3-
1Kb-m1 with p50 or p65 were lower than with pGL3-1Kb
(p,0.0001 for p65; p=0.0043 for p50), and levels for pGL3-1Kb-
m2 were lower with p65 (p,0.0001), but did not reach statistical
significance with p50 (p=0.06). Expression levels did not return to
baseline levels with either pGL3-1Kb-m1 or pGL3-1Kb-m2 in the
presence of p65 or p50. These findings confirm the importance of
NF-kB binding to this particular recognition site at 2833 bp for
basal let-7 promoter activity and the promoter’s responsiveness to
ectopically expressed NF-kB subunits. They also indicate further
that there are likely to be other important regulators of let-7
expression in addition to this particular binding site.
In order to assess whether NF-kB activation of the let-7a-3
promoter proceeds exclusively through the NF-kB recognition site
at 2833 bp, or whether other putative binding sites might also
contribute to NF-kB activity, we extended our analysis to an
additional putative NF-kB responsive element within the promoter
at bp 2947. We performed site-directed mutagenesis on the wild-
type sequence 59 AGCTTTTCCCC 39 and converted it to 59
ATTTCCCC 39 to form pGL3-1Kb-m3. The pGL3-1Kb, pGL3-
1Kb-m1 or pGL3-1Kb-m3 plasmids were co-transfected into
HEK293T cells along with plasmids containing p50 or p65
subunits or no insert and luciferase activity was monitored.
Transfection with either pGL3-1Kb-m1 or pGL3-1Kb-m3
resulted in significantly reduced basal activity compared to
transfection with the wildtype pGL3-1Kb plasmid (p,0.0001)
(Figure 4). Both pGL3-1Kb-m1 and pGL3-1Kb-m3 also resulted
in reduced luciferase activity with p65 overexpression (p,0.0001).
Cells transfected with pGL3-1Kb-m1 exhibited a larger decrease
in luciferase activity in the presence of p50 than cells transfected
with pGL3-1Kb-m3 (p,0.0001) and a larger decrease in luciferase
activity in the presence of p65 than cells transfected with pGL3-
1Kb-m3 (p,0.05). Thus, both the 2833 and 2947 sites are
expected to contribute to NF-kB-regulated induction of the let-7a-
3/b promoter, with the 2833 bp site likely having a larger
contribution to NF-kB responsiveness than the 2947 site.
NF-kB induces expression from the let-7a/b endogenous
promoter but does not result in elevated levels of mature
let-7a and let-7b transcripts
We tested whether transfection of NF-kB subunits results in an
induction of endogenous mature let-7a or let-7b. Empty vector
plasmids or plasmids expressing p50 or p65 were transfected into
293T cells and levels of pri-let-7a and pri-let-7b were monitored with
real-time PCR using TaqMan pri-miRNA assays. Pri-let-7a and
pri-let-7b transcript levels in each sample were normalized to b-
actin levels in the same sample as a control. Both p65 and p50
overexpression resulted in a statistically significant increase in both
pri-let-7a and pri-let-7b (Figure 5A). Thus, not only do NF-kB
subunits activate luciferase activity when the luciferase gene is
placed downstream of let-7 promoter sequences, but the
endogenous let-7a3/let-7b genes are also activated by NF-kB
subunits in HEK293T cells.
We then tested whether introduction of NF-kB subunits results
in an increase in mature let-7a or let-7b miRNA abundance. p50 or
p65 were transfected into 293T cells and levels of the processed let-
7a or let-7b were monitored with real-time PCR using TaqMan
MicroRNA assays. U6 was used as a normalization control.
Despite the fact that overexpression of p65 and p50 resulted in an
induction of pri-let-7a3 and pri-let-7b, we detected a significant
decrease in mature let-7a and a moderate reduction of mature let-
7b miRNA levels in p50 or p65 overexpressing cells (Figure 5B).
NF-kB induces Lin28B
Our results indicate that while levels of the pri-let-7a3/let-7b
transcript are induced in response to NF-kB subunits, the final
Figure 4. The NF-kB binding site at bp 2947 also regulates let-7a-3 promoter activity. HEK293T cells were co-transfected with plasmids
containing either 1 kb of the wild-type let-7a-3/b promoter or one of two plasmids with mutated NF-kB recognition sites, one at bp 2833 (pGL3-1Kb-
m1) and one at bp 2947 (pGL3-1Kb-m3), and plasmids containing NF-kB subunits. Normalization control pRenilla was also transfected. Luciferase
activity was monitored and the ratio of firefly to Renilla luciferase was determined. The fold-change compared with the pGL3 vector is plotted. Two
biological replicates were performed and for each biological replicate, three technical replicates were analyzed. Mean values are indicated and error
bars designate the standard deviation.
doi:10.1371/journal.pone.0031240.g004
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studies had indicated that Lin28 is induced in response to NF-kB
in Src-transformed MCF10A cells [29]. Increased Lin28B, a
protein that prevents the processing of let-7 pri-miRNAs, could
potentially explain the fact that the increased levels of the pri-
microRNAs did not result in elevated levels of the mature
Figure 5. NF-kB induces pri-let-7a/b but not fully processed let-7a/b, possibly because of an induction of Lin28B. A. Pri-let-7a-3 and pri-
let-7b are induced by p65 and p50 in 293T cells. 293T cells were transfected with an empty vector or a vector expressing NF-kB subunits p50 or p65.
Real-time PCR was performed for pri-let-7a-3 and pri-let-7b. Data were normalized to b-actin. The data represent four biological replicates each
performed in triplicate. Mean values are shown and error bars indicate standard error. One asterisk indicates p,0.05; three asterisks indicate p,0.001.
B. Mature let-7a and let-7b are not induced by p50 or p65 in HEK293T cells. HEK293T cells were transfected with an empty vector or a vector
expressing NF-kB subunits p50 or p65. Real-time PCR was performed and the ratio of let-7a or let-7b to U6 small nuclear RNA was determined. Error
bars indicate standard error and represent an average from two biological replicates each performed in triplicate. Asterisk indicates p,0.05. C. Lin28B
levels increase in HEK293T cells transfected with NF-kB subunits. HEK293T cells were transfected with an empty vector or a vector expressing NF-kB
subunits p50 or p65. Real-time PCR was performed and the Lin28B to b-actin expression was determined. Error bars indicate standard error and
represent an average from three biological replicates each performed in triplicate. Asterisk indicates p,0.05. D. Lin28B protein levels increase
modestly in HEK293T cells expressing NF-kB subunits. Lin28B, p50 and p65 protein levels were monitored by Western blotting in lysates prepared
from HEK293T cells transfected with an empty vector, or vectors expressing p50 or p65 (left). Anti-flag antibodies were used to measure exogenously
expressed p50 and p65. Image J was used to quantify Lin28B protein levels for each sample in three independent experiments, and the fold change
of Lin28B isoform I and II combined from samples expressing p50 or p65 to the empty control vector is plotted (right). Error bars represent standard
error. Two asterisks indicates p,0.01. Three asterisks indicates p,0.001.
doi:10.1371/journal.pone.0031240.g005
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cells and monitored Lin28B levels with gene-specific primers and
probes using real-time PCR and normalized to a b-actin control.
Lin28B transcript levels increased in response to introduction of
either p50 or p65 (Figure 5C). Overexpression of p50 or p65
resulted in a modest increase in Lin28B protein levels (Figure 5D).
Increased Lin28B may partially explain the lack of up-regulation
of the mature microRNA in response to p50 or p65 overexpres-
sion.
Discussion
In order to better understand the regulation of the let-7 miRNA
family, we investigated one particular genomic region that
contains let-7a-3 and let-7b. We discovered that the let-7a-3
promoter is responsive to NF-kB subunits p50 and p65. Similarly,
Garzon and colleagues discovered that ATRA treatment of acute
promeylocytic leukemia cell lines resulted in induction of let-7a and
let-7b, and that NF-kB inhibitors abrogated this induction [30].
Using chromatin immunoprecipitation, Garzon and colleagues did
not detect a significant amount of binding of p65 to the NF-kB
motif within the let-7 promoter and concluded that p50/p50
homodimers are likely responsible for the NF-kB-responsiveness of
the promoter. Their experiments with small interfering RNAs
against p50 and p65, however, suggested that p65 binding sites
might be present. In our study, we discovered that luciferase
activity is induced by overexpression of either p50 or p65 in 293,
293T, HeLa and 3T3 cells containing a reporter with the let-7a-3
promoter was cloned upstream of the coding region for luciferase.
In our experiments, induction with p65 was stronger than p50.
Since p65 contains a transactivation domain and p50 does not,
cell-type specificity in the activity of transfected p50 may reflect
differences in the presence of endogenous co-factors like p65.
Garzon and colleagues also investigated the importance of the
NF-kB binding site at 2833 and concluded that this particular site
is mostly responsible for NF-kB responsiveness [30]. This
particular binding site was the only one to which p50 bound in
their experiments. Further, in their studies, site-directed muta-
genesis of this site essentially eliminated NF-kB-induced expres-
sion. While our data also support the conclusion that the
recognition site at bp 2833 is important under basal conditions
and upon introduction of NF-kB subunits, in our studies,
abrogation of the 2833 bp site reduced but did not eliminate
NF-kB responsiveness. We discovered that a second site at bp
2947 also likely contributes to the induction of let-7 upon NF-kB
activation.
Overexpression of p65 resulted in an induction of pri-let7a-3 and
pri-let-7b, indicating that these two miRNAs likely form a
polycistron. However, levels of the final processed let-7a or let-7b
were not induced as assessed by real-time PCR. One potential
explanation for the lack of final microRNA is the induction of
Lin28, a potent regulator of let-7 microRNA biogenesis, that
recruits a terminal transferase Tut4 to add terminal uridines to let-
7 miRNAs, resulting in their degradation [33]. In 293T cells, in
accord with previously reported results in Src-transformed
MCF10A cells [29], Lin28B transcript and protein levels were
induced by p50 or p65, although the protein level induction was
modest. Increased Lin28B levels in response to NF-kB subunits
could explain the lack of an increase in mature let-7a and let-7b.
NF-kB can have different effects depending on the cell type and
cellular context, in some cases promoting proliferation
[25,27,34,35], and in other instances causing cell cycle arrest
[36,37]. This duality could potentially reflect, in part, the effect of
NF-kBo nlet-7. Under certain circumstances, NF-kB activation
might result in increased let-7 transcription and in higher levels of
processed let-7, as observed by Garzon and colleagues in NB4 cells
[30]. Since let-7 can act as a mediator of cell cycle exit, and is
associated with a commitment to differentiation rather than self-
renewal, let-7 induction by NF-kB could be part of the mechanism
by which NF-kB contributes to cell cycle exit. This could be
advantageous in response to genotoxic damage, for instance, by
providing extra time during G2/M arrest for repairing damage
before resuming the cell cycle [10].
In other situations, NF-kB-mediated activation of transcription
of the pri-miRNA for let-7a-3/let-7b could inhibit cell cycle
progression in a delayed and regulated manner. As an analogy, the
core embryonic stem cell transcription factors—Oct4, Nanog,
Sox2 and Tcf3—promote the transcription of the miRNA let-7g
and Lin28 [38]. When stem cells receive a differentiation signal,
Lin28B-mediated inhibition is released and mature let-7 starts to
accumulate. By transcribing, but initially repressing let-7, embry-
onic stem cells are poised for rapid and efficient cellular
differentiation. Similarly, our results suggest that NF-kB activates
the let-7a-3 promoter and Lin28B in HEK293T cells. While
mature let-7a and let-7b do not accumulate immediately, the cells
could be poised for elevated let-7 activity if Lin28B or other
processing factors were later inhibited.
NF-kB activation can also result in lower let-7 levels, thus
increased cellular inflammation and increased tumorigenesis [29].
These results, taken together with ours, suggest a possible
mechanism for the dual role of NF-kB in both inhibiting and
promoting tumorigenesis. In cells expressing Lin28B or other
factors that inhibit pri-let-7 processing, NF-kB activation would
result in unchanged or reduced let-7 levels. In committed cells that
lack the critical regulatory factors, for example hematopoietic cells,
NF-kB activity results in the induction of mature let-7. This could
allow for removal of damaged cells or provide more time for
repair. In this hypothetical model Lin28 or other miRNA
biogenesis regulatory molecules might contribute to the determi-
nation of the ultimate functional effect of NF-kB.
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